157 related articles for article (PubMed ID: 15787968)
1. Immunostimulants and Toll-like receptor ligands obtained by screening combinatorial lipopeptide collections.
Reutter F; Jung G; Baier W; Treyer B; Bessler WG; Wiesmüller KH
J Pept Res; 2005 Mar; 65(3):375-83. PubMed ID: 15787968
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of thiol-reactive lipopeptide adjuvants. Incorporation into liposomes and study of their mitogenic effect on mouse splenocytes.
Roth A; Espuelas S; Thumann C; Frisch B; Schuber F
Bioconjug Chem; 2004; 15(3):541-53. PubMed ID: 15149182
[TBL] [Abstract][Full Text] [Related]
3. Synthetic S-(2,3-dihydroxypropyl)-cysteinyl peptides derived from the N-terminus of the cytochrome subunit of the photoreaction centre of Rhodopseudomonas viridis enhance murine splenocyte proliferation.
Metzger JW; Beck-Sickinger AG; Loleit M; Eckert M; Bessler WG; Jung G
J Pept Sci; 1995; 1(3):184-90. PubMed ID: 9222995
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 6-independent signaling by diacylated lipopeptides.
Buwitt-Beckmann U; Heine H; Wiesmüller KH; Jung G; Brock R; Akira S; Ulmer AJ
Eur J Immunol; 2005 Jan; 35(1):282-9. PubMed ID: 15580661
[TBL] [Abstract][Full Text] [Related]
5. Synthetic lipopeptide adjuvants and Toll-like receptor 2--structure-activity relationships.
Spohn R; Buwitt-Beckmann U; Brock R; Jung G; Ulmer AJ; Wiesmüller KH
Vaccine; 2004 Jun; 22(19):2494-9. PubMed ID: 15193414
[TBL] [Abstract][Full Text] [Related]
6. Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1.
Manukyan M; Triantafilou K; Triantafilou M; Mackie A; Nilsen N; Espevik T; Wiesmüller KH; Ulmer AJ; Heine H
Eur J Immunol; 2005 Mar; 35(3):911-21. PubMed ID: 15714590
[TBL] [Abstract][Full Text] [Related]
7. Lipopeptide structure determines TLR2 dependent cell activation level.
Buwitt-Beckmann U; Heine H; Wiesmüller KH; Jung G; Brock R; Ulmer AJ
FEBS J; 2005 Dec; 272(24):6354-64. PubMed ID: 16336272
[TBL] [Abstract][Full Text] [Related]
8. Novel glycolipid TLR2 ligands of the type Pam2Cys-α-Gal: synthesis and biological properties.
Thomann JS; Monneaux F; Creusat G; Spanedda MV; Heurtault B; Habermacher C; Schuber F; Bourel-Bonnet L; Frisch B
Eur J Med Chem; 2012 May; 51():174-83. PubMed ID: 22483966
[TBL] [Abstract][Full Text] [Related]
9. Triacyl-lipopentapeptide adjuvants: TLR2-dependent activation of macrophages and modulation of receptor-mediated cell activation by altering acyl-moieties.
Müller SD; Müller MR; Huber M; Esche Uv Uv; Kirschning CJ; Wagner H; Bessler WG; Mittenbühler K
Int Immunopharmacol; 2004 Oct; 4(10-11):1287-300. PubMed ID: 15313427
[TBL] [Abstract][Full Text] [Related]
10. Effect of synthetic lipopeptides formulated in liposomes on the maturation of human dendritic cells.
Espuelas S; Roth A; Thumann C; Frisch B; Schuber F
Mol Immunol; 2005 Apr; 42(6):721-9. PubMed ID: 15781116
[TBL] [Abstract][Full Text] [Related]
11. Chirality of TLR-2 ligand Pam3CysSK4 in fully synthetic peptide conjugates critically influences the induction of specific CD8+ T-cells.
Khan S; Weterings JJ; Britten CM; de Jong AR; Graafland D; Melief CJ; van der Burg SH; van der Marel G; Overkleeft HS; Filippov DV; Ossendorp F
Mol Immunol; 2009 Mar; 46(6):1084-91. PubMed ID: 19027958
[TBL] [Abstract][Full Text] [Related]
12. Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes.
Bessler WG; Cox M; Lex A; Suhr B; Wiesmüller KH; Jung G
J Immunol; 1985 Sep; 135(3):1900-5. PubMed ID: 3874908
[TBL] [Abstract][Full Text] [Related]
13. Lipolanthionine peptides act as inhibitors of TLR2-mediated IL-8 secretion. Synthesis and structure-activity relationships.
Seyberth T; Voss S; Brock R; Wiesmüller KH; Jung G
J Med Chem; 2006 Mar; 49(5):1754-65. PubMed ID: 16509590
[TBL] [Abstract][Full Text] [Related]
14. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells.
Roelofs MF; Joosten LA; Abdollahi-Roodsaz S; van Lieshout AW; Sprong T; van den Hoogen FH; van den Berg WB; Radstake TR
Arthritis Rheum; 2005 Aug; 52(8):2313-22. PubMed ID: 16052591
[TBL] [Abstract][Full Text] [Related]
15. A synthetic analogue of Escherichia coli lipoprotein, tripalmitoyl pentapeptide, constitutes a potent immune adjuvant.
Lex A; Wiesmüller KH; Jung G; Bessler WG
J Immunol; 1986 Oct; 137(8):2676-81. PubMed ID: 3531339
[TBL] [Abstract][Full Text] [Related]
16. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
[TBL] [Abstract][Full Text] [Related]
17. Solid-phase synthesis of biologically active lipopeptides as analogs for spirochetal lipoproteins.
DeOgny L; Pramanik BC; Arndt LL; Jones JD; Rush J; Slaughter CA; Radolf JD; Norgard MV
Pept Res; 1994; 7(2):91-7. PubMed ID: 8012126
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships in human Toll-like receptor 2-specific monoacyl lipopeptides.
Salunke DB; Shukla NM; Yoo E; Crall BM; Balakrishna R; Malladi SS; David SA
J Med Chem; 2012 Apr; 55(7):3353-63. PubMed ID: 22385476
[TBL] [Abstract][Full Text] [Related]
19. CD14 directly binds to triacylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex.
Nakata T; Yasuda M; Fujita M; Kataoka H; Kiura K; Sano H; Shibata K
Cell Microbiol; 2006 Dec; 8(12):1899-909. PubMed ID: 16848791
[TBL] [Abstract][Full Text] [Related]
20. Relation between the biologic activities and chemical structures of synthetic microbial lipopeptide analogs in mice.
Shimizu T; Haketa Y; Iwamoto Y; Yanagihara Y; Kurimura M; Ochiai A; Achiwa K
Mol Biother; 1992 Dec; 4(4):184-7. PubMed ID: 1476672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
